Mod GRF 1-29 (No DAC) (5mg)
Mod GRF 1-29 — Non-DAC GHRH Fragment Research
Order Mod GRF 1-29 (No DAC) (5mg) online for laboratory research. Compare the listed vial options and current price, then add your selection to cart and continue to checkout. Review available COA records for the exact product, strength and lot. Research Use Only; not for human or veterinary use.
Mod GRF 1-29 (CJC-1295 No DAC) is listed for growth hormone laboratory research. Catalog vial contents are 5mg; select the required strength before ordering. This material is supplied for Research Use Only, not as a medicine or a product for human or veterinary use.
Research Applications & Benefits
- Modified GHRH fragment research
- DAC versus No DAC identity comparison
- Sequence-specific evidence review
What is Mod GRF 1-29 (CJC-1295 No DAC)?
Mod GRF 1-29 is a modified 29-amino-acid fragment of growth-hormone-releasing hormone (GHRH). It is also sold under the name CJC-1295 No DAC. This catalog lists a 5mg vial for in-vitro laboratory research.
Listed vial contents: 5mg. These are supplied quantities, not administration doses. Current pricing and availability are shown in the strength selector.
Which identity should I verify?
The catalog also lists CJC-1295 with DAC. The shared naming convention does not make these materials interchangeable. Check the exact sequence, absence of DAC, molecular mass and salt form in an original matching lot document.
What mechanisms are being studied?
Researchers study modified GHRH fragments as signals at the GHRH receptor. This material is listed without the albumin-binding DAC modification. Its identity and behavior must be assessed separately from long-acting CJC-1295 with DAC.
What are the research questions?
- Receptor signaling by a defined modified GHRH fragment
- Differences between DAC-containing and non-DAC constructs
- Sequence verification before comparing published findings
What does the published work describe?
Jetté and colleagues' 2005 paper and Teichman and colleagues' 2006 trials concern long-lasting CJC-1295. They provide context for the DAC construct, not direct validation of this No DAC product. Those findings cannot establish this vial's duration of action, effects or equivalence to the tested material.
What could future research explore?
Future work could compare defined GHRH analogs in the same experimental system. Such comparisons need confirmed sequences and matched study conditions. Possible treatment applications remain separate from the sale of this in-vitro research material.
These are research directions, not established applications of the product sold here.
What are the limits of this evidence?
The references below explain the identity distinction; they are not direct evidence of benefit for this Mod GRF 1-29 vial. They do not support claims of synergy with another peptide, precise hormone timing or established human safety.
Study references
- Jetté L, et al. Identification of CJC-1295 as a long-lasting GRF analog. Endocrinology. 2005. PMID 15817669
- Teichman SL, et al. Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults. J Clin Endocrinol Metab. 2006. PMID 16352683
How should I check lot documentation?
Match the product, strength and lot to an original analysis document. Literature describes experimental findings; it does not verify the contents of this inventory. A report is evidence only for the product, strength and lot it names.
How is Mod GRF 1-29 (CJC-1295 No DAC) handled in the lab?
For Mod GRF 1-29 (CJC-1295 No DAC), record the product code MODGRF, selected strength and lot before opening. Follow the material-specific safety data sheet and laboratory SOP, with appropriate gloves, eye protection and containment. For a documented dry preparation, let the sealed vial equilibrate before opening to reduce condensation; minimize time open and use clean, compatible vessels.
Choose a solvent for Mod GRF 1-29 (CJC-1295 No DAC) from the documented sequence or chemical identity, salt form and assay requirements. Test a small portion first and record pH, solvent composition and clarity. Do not assume one diluent works for every research material; include a solvent-only control and establish compatibility before using the stock in an assay.
For Mod GRF 1-29 (CJC-1295 No DAC), calculate mass concentration as measured material mass divided by final solution volume. Calculate molarity only with a documented molecular weight for the supplied chemical form; no usable molecular weight is established by the blank catalog field. Where available, use matched-lot net content rather than treating chromatographic purity as a mass correction. Record both stock concentration and subsequent dilution factors.
Use the documented storage conditions for the supplied Mod GRF 1-29 (CJC-1295 No DAC) form and lot. For a documented lyophilized preparation, keep the vial sealed and protected from moisture; for solutions, validate temperature, light exposure and holding time in the assay. Use compatible single-use aliquots when appropriate to reduce repeated freeze-thaw. No universal temperature or 28-day solution shelf life is established by the catalog name.
A Mod GRF 1-29 (CJC-1295 No DAC) laboratory protocol should record identity, product code MODGRF, strength, lot, applicable analysis results, solvent and pH, stock concentration, dilution sequence, vessel type, storage history and assay endpoints. Include vehicle and reference controls, independent replicates and predefined acceptance criteria. Separate handling validation from biological interpretation; these notes do not provide administration or dosing instructions.
Research Use Only. Not for human consumption, therapeutic, veterinary or any in-vivo use.
Product Specifications
- Compound
- Mod GRF 1-29 (CJC-1295 No DAC)
- CAS Number
- Molecular Weight
- HPLC Purity Specification
- ≥99%
- Category
- Growth Hormone
- Starting Price
- $39.00 USD
- Country of Origin
- United States
- Shipping
- Cold-chain insulated packaging, fast domestic delivery
- Payment
- Card, ACH, and cryptocurrency (10% discount)
Quality & Verification
Mod GRF 1-29 (CJC-1295 No DAC) has a catalog purity specification of ≥99%; this is not a measured result for every vial. Match the product, exact strength, batch and lot to its analysis record and read only the reported fields. HPLC peak-area purity, measured content and endotoxin are separate measurements. A blank field means no result is reported, not zero or passed. A purity percentage alone does not establish identity, sterility or suitability for human use.
Frequently Asked Questions
What is Mod GRF 1-29 (CJC-1295 No DAC)?
Mod GRF 1-29 (CJC-1295 No DAC) is listed for growth hormone laboratory research. Catalog vial contents are 5mg; select the required strength before ordering. This material is supplied for Research Use Only, not as a medicine or a product for human or veterinary use.
What strengths of Mod GRF 1-29 (CJC-1295 No DAC) are available?
The catalog lists 5mg. These labels describe vial contents, not administration doses. Select the required strength for current pricing and availability; match analysis records to that exact strength and lot.
How should I interpret Mod GRF 1-29 (CJC-1295 No DAC) purity results?
Mod GRF 1-29 (CJC-1295 No DAC) has a catalog purity specification of ≥99%; this is not a measured result for every vial. Match the product, exact strength, batch and lot to its analysis record and read only the reported fields. HPLC peak-area purity, measured content and endotoxin are separate measurements. A blank field means no result is reported, not zero or passed. A purity percentage alone does not establish identity, sterility or suitability for human use.
How should Mod GRF 1-29 (CJC-1295 No DAC) be handled in the laboratory?
For Mod GRF 1-29 (CJC-1295 No DAC), record the product code MODGRF, selected strength and lot before opening. Follow the material-specific safety data sheet and laboratory SOP, with appropriate gloves, eye protection and containment. For a documented dry preparation, let the sealed vial equilibrate before opening to reduce condensation; minimize time open and use clean, compatible vessels.
How do I choose a laboratory solvent for Mod GRF 1-29 (CJC-1295 No DAC)?
Choose a solvent for Mod GRF 1-29 (CJC-1295 No DAC) from the documented sequence or chemical identity, salt form and assay requirements. Test a small portion first and record pH, solvent composition and clarity. Do not assume one diluent works for every research material; include a solvent-only control and establish compatibility before using the stock in an assay.
How do I calculate a Mod GRF 1-29 (CJC-1295 No DAC) stock concentration?
For Mod GRF 1-29 (CJC-1295 No DAC), calculate mass concentration as measured material mass divided by final solution volume. Calculate molarity only with a documented molecular weight for the supplied chemical form; no usable molecular weight is established by the blank catalog field. Where available, use matched-lot net content rather than treating chromatographic purity as a mass correction. Record both stock concentration and subsequent dilution factors.
How should Mod GRF 1-29 (CJC-1295 No DAC) be stored after preparation?
Use the documented storage conditions for the supplied Mod GRF 1-29 (CJC-1295 No DAC) form and lot. For a documented lyophilized preparation, keep the vial sealed and protected from moisture; for solutions, validate temperature, light exposure and holding time in the assay. Use compatible single-use aliquots when appropriate to reduce repeated freeze-thaw. No universal temperature or 28-day solution shelf life is established by the catalog name.
What should a Mod GRF 1-29 (CJC-1295 No DAC) lab protocol document?
A Mod GRF 1-29 (CJC-1295 No DAC) laboratory protocol should record identity, product code MODGRF, strength, lot, applicable analysis results, solvent and pH, stock concentration, dilution sequence, vessel type, storage history and assay endpoints. Include vehicle and reference controls, independent replicates and predefined acceptance criteria. Separate handling validation from biological interpretation; these notes do not provide administration or dosing instructions.
Does Fmoc or Boc synthesis explain this Mod GRF 1-29 (CJC-1295 No DAC) product?
Fmoc and Boc are peptide protecting-group strategies, not proof of how this Mod GRF 1-29 (CJC-1295 No DAC) lot was made. For sequence-defined peptides, synthesis review can examine deletion products, incomplete deprotection and modifications using the method and matching analytical evidence. A single chromatographic peak does not by itself establish sequence.
Is Mod GRF 1-29 (CJC-1295 No DAC) for human use?
No. Mod GRF 1-29 (CJC-1295 No DAC) is strictly Research Use Only. It is not intended for human or veterinary use, diagnosis or treatment. Laboratory handling guidance is not an administration protocol.
Research Use Only. This product is intended for licensed laboratory research and is not for human or veterinary use.
